Suppr超能文献

相似文献

1
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides.
J Psychiatr Res. 2010 Jul;44(9):591-7. doi: 10.1016/j.jpsychires.2009.11.013. Epub 2009 Dec 16.
2
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
Int J Neuropsychopharmacol. 2010 Apr;13(3):373-86. doi: 10.1017/S146114570999023X. Epub 2009 Jul 17.
3
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects.
J Psychopharmacol. 2015 Nov;29(11):1137-45. doi: 10.1177/0269881115599388. Epub 2015 Aug 7.
7
Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol.
J Neurochem. 2008 Jan;104(1):233-43. doi: 10.1111/j.1471-4159.2007.04956.x. Epub 2007 Oct 17.
9
Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
Neuropsychopharmacology. 2007 Jan;32(1):117-26. doi: 10.1038/sj.npp.1301034. Epub 2006 Feb 8.
10
Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders.
Biochem Pharmacol. 2018 Nov;157:258-265. doi: 10.1016/j.bcp.2018.08.012. Epub 2018 Aug 10.

引用本文的文献

1
2
Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.
BMC Psychiatry. 2024 Aug 8;24(1):551. doi: 10.1186/s12888-024-05986-8.
3
Omics Approaches to Investigate the Pathogenesis of Suicide.
Biol Psychiatry. 2024 Dec 15;96(12):919-928. doi: 10.1016/j.biopsych.2024.05.017. Epub 2024 May 29.
4
How depression and antidepressant drugs affect endocannabinoid system?-review of clinical and preclinical studies.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4511-4536. doi: 10.1007/s00210-023-02938-z. Epub 2024 Jan 27.
6
Molecular Changes Associated with Suicide.
Int J Mol Sci. 2023 Nov 24;24(23):16726. doi: 10.3390/ijms242316726.
7
Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.
Neuropsychopharmacology. 2023 Jan;48(1):37-53. doi: 10.1038/s41386-022-01438-7. Epub 2022 Sep 13.
8
Biomarkers of the Endocannabinoid System in Substance Use Disorders.
Biomolecules. 2022 Mar 3;12(3):396. doi: 10.3390/biom12030396.
9
The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System.
Alcohol Res. 2022 Jan 27;42(1):03. doi: 10.35946/arcr.v42.1.03. eCollection 2022.

本文引用的文献

1
Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling.
Genes Brain Behav. 2009 Mar;8(2):203-11. doi: 10.1111/j.1601-183X.2008.00463.x. Epub 2008 Dec 3.
3
Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
Alcohol Clin Exp Res. 2008 Nov;32(11):1976-83. doi: 10.1111/j.1530-0277.2008.00786.x. Epub 2008 Sep 6.
5
Abnormal temporal difference reward-learning signals in major depression.
Brain. 2008 Aug;131(Pt 8):2084-93. doi: 10.1093/brain/awn136. Epub 2008 Jun 25.
7
The neuropharmacology of impulsive behaviour.
Trends Pharmacol Sci. 2008 Apr;29(4):192-9. doi: 10.1016/j.tips.2008.01.002. Epub 2008 Mar 4.
8
Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex.
Alcohol Clin Exp Res. 2008 Apr;32(4):593-9. doi: 10.1111/j.1530-0277.2007.00610.x. Epub 2008 Jan 30.
9
Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice.
Psychoneuroendocrinology. 2008 Jan;33(1):54-67. doi: 10.1016/j.psyneuen.2007.09.008. Epub 2007 Oct 31.
10
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.
Pharmacol Res. 2007 Nov;56(5):360-6. doi: 10.1016/j.phrs.2007.09.003. Epub 2007 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验